In its continued bid to waylay the launch of MSN Pharmaceuticals’ proposed Entresto generic, Novartis has told a federal judge in Delaware that time is of the essence. Novartis has submitted a request ...
Swiss pharmaceutical firm Novartis said Thursday that it expects its Kisqali breast cancer treatment to be the next blockbuster drug within its portfolio, as it looks to shift reliance away from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results